Phase II study of gemcitabine/vinorelbine (GV) as first or second line chemotherapy in patients with metastatic soft tissue sarcoma (STS).

被引：0
|
作者：
Morgan, JA [1 ]
George, S [1 ]
Desai, J [1 ]
Amand, MS [1 ]
Horton, D [1 ]
Wilkins, E [1 ]
Manola, J [1 ]
Demetri, GD [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9009
引用
收藏
页码：820S / 820S
页数：1
相关论文
共 50 条
  • [21] A phase II study of gimatecan as salvage treatment in patients with advanced or metastatic soft tissue sarcoma (STS) relapsing after anthracycline / ifosfamide - based chemotherapy regimens
    Biron, P.
    Reichardt, P.
    Grosso, F.
    Le Cesne, A.
    Poveda, A.
    McCanna, S.
    Zanna, C.
    Brienza, S.
    Ray-Coquard, I.
    Blay, J. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS)
    Revathi Suppiah
    Laura Wood
    Paul Elson
    George T. Budd
    Investigational New Drugs, 2006, 24 : 509 - 514
  • [23] Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS)
    Suppiah, Revathi
    Wood, Laura
    Elson, Paul
    Budd, George T.
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (06) : 509 - 514
  • [24] Analysis of toxicity in a phase II study of sorafenib in soft tissue sarcoma (STS)
    Keohan, M.
    D'Adamo, D.
    Qin, L.
    Saulle, M.
    Caltieri, L.
    Schuetze, S.
    Wright, J. J.
    Schwartz, G.
    Maki, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS).
    Suppiah, R
    Budd, GT
    Wood, L
    Elson, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 831S - 831S
  • [26] A phase II study of anlotinib in the first-line treatment of locally advanced or metastatic soft tissue sarcoma.
    Huang, Xin
    Ye, Zhaoming
    Li, Tao
    Wei, Yongzhong
    Wang, Shoufeng
    Liu, Yunxia
    Chen, Jia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] Phase II randomized study of gemcitabine plus vinorelbine versus gemcitabine plus mitoxantrone in advanced metastatic breast cancer elderly women: A first-line chemotherapy
    Latorre, A.
    Monticelli, G.
    Giotta, F.
    Calabrese, R.
    Lorusso, V.
    Colucci, G.
    ANNALS OF ONCOLOGY, 2006, 17 : VII145 - VII146
  • [28] Phase II Study of Gemcitabine and Vinorelbine as a Combination Chemotherapy for the Second-Line Treatment of Nonsmall Cell Lung Carcinoma
    Lee, EunJoo
    Ha, EunSil
    Park, SangHoon
    Hur, GyuYoung
    Jung, KiHwan
    Jeong, HyeCheol
    Lee, SungYong
    Kim, JeHyeong
    Lee, SangYeub
    Sin, Chol
    Shim, JaeJeong
    In, KwangHo
    Kang, KyungHo
    Yoo, Sehwa
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2005, 59 (05) : 510 - 516
  • [29] Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study
    Gelderblom, H.
    Blay, J. Y.
    Seddon, B. M.
    Leahy, M.
    Ray-Coquard, I.
    Sleijfer, S.
    Kerst, J. M.
    Rutkowski, P.
    Bauer, S.
    Ouali, M.
    Marreaud, S.
    van der Straaten, R. J. H. M.
    Guchelaar, H-J
    Weitman, S. D.
    Hogendoorn, P. C. W.
    Hohenberger, P.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (02) : 388 - 396
  • [30] Phase I/II study of docetaxel (D), gemcitabine (G), and bevacizumab (B) in patients (pts) with advanced or recurrent soft tissue sarcoma (STS)
    Verschraegen, C. F.
    Fekrazad, H. M.
    Rabinowitz, I.
    Quinn, R.
    Snyder, D.
    Judson, P.
    Purdy, M.
    Lee, F. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345